Skip to content

Pharminent

cropped-ChatGPT-Image-Jun-22-2026-05_46_48-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Manufacturing
  • Eisai claims UK grant to expand manufacturing site
  • Manufacturing

Eisai claims UK grant to expand manufacturing site

Pharmaphorum

Eisai has been given a grant from the UK that will support a 48m plan to add cold chain capabilities to its facility in Hatfield, Hertfordshire.

Read full story

pharminent June 15, 2026 (Last updated: June 15, 2026)

Pharmaphorum

Eisai has been given a grant from the UK that will support a 48m plan to add cold chain capabilities to its facility in Hatfield, Hertfordshire.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Key pipeline drug for Lundbeck delivers in Cushing syndrome
Next: Next Post

Related Stories

  • Manufacturing

FDA Selects Seven for PreCheck Pilot to Advance Drug Manufacturing

pharminent July 1, 2026
  • Manufacturing

SK pharmteco Launches SKyvec Viral Vector Platform for Gene Therapy

pharminent June 24, 2026
  • Manufacturing

pharminent June 17, 2026

You May Have Missed

sample_feature_2026-06-22
  • News

Novartis Acquires UK ADC Specialist Myricx Bio for Up to $1.5 Billion

pharminent July 6, 2026
  • M&A / Deals

Novartis to acquire Myricx Bio in up to $1.5bn deal

pharminent July 6, 2026
  • Market Access

UK, pharma industry pilot rapid access routes for medicines

pharminent July 5, 2026
  • Market Access

Medicare GLP-1 Bridge Launches July 1 With $50 Copays

pharminent July 3, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.